Stock Rating Upgrade The Value Trend Rating for Standard Motor Products Inc. (NYSE: SMP) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]
Stock Rating Downgrade The Value Trend Rating for Resmed Inc (NYSE: RMD) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for RF Industries Ltd (NASDAQ: RFIL) weakened during the last several trading days. RFIL’s current Value Trend Rating is C and […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Piper Sandler Cos (NYSE: PIPR) weakened during the last several trading days. PIPR’s current Value Trend Rating is C and […]
Stock Rating Downgrade The Value Trend Rating for OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) weakened of late from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Stock Rating Upgrade Of late the Value Trend Rating for Nucor Corp (NYSE: NUE) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 3/7/25, Nucor Corp (NYSE: NUE) […]
Stock Rating Upgrade The Value Trend Rating for NewtekOne Inc (NASDAQ: NEWT) rose significantly recently from C to A reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
Stock Rating Upgrade In the last week the Value Trend Rating for NOW Inc (NYSE: DNOW) rose significantly from C to A reflecting improving fundamentals and high Appreciation Potential. Recent Price Action NOW Inc (NYSE: […]
Stock Rating Upgrade The Value Trend Rating for L.B. Foster Co (NASDAQ: FSTR) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Iovance Biotherapeutics Inc (NASDAQ: IOVA) rose significantly in recent days. IOVA’s current Value Trend Rating is C and the prior […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research